Fatty acid metabolism: beta-oxidation, fatty acid synthesis, and the acetyl-CoA hub

Intuition Beginner

Fats store an enormous amount of energy in a compact form. A single molecule of a common fatty acid like palmitate (16 carbons) yields over 100 ATP when fully oxidized — more than six times the energy per carbon compared to glucose. This energy density is why adipose tissue serves as the body's primary long-term fuel reserve.

When your cells need that stored energy, they chop the fatty acid into two-carbon pieces through a repeating cycle called beta-oxidation. Each round removes one acetyl-CoA unit from the tail end. The acetyl-CoA then enters the citric acid cycle and electron transport chain to produce ATP.

When energy is abundant — after a large meal, for instance — your cells run the reverse pathway. Fatty acid synthesis stitches two-carbon units together into long chains, using a carrier called malonyl-CoA. The same molecule, acetyl-CoA, sits at the center of both processes, acting as a metabolic hub that connects sugar breakdown, fat breakdown, fat construction, and several other pathways.

Visual Beginner

The diagram above shows how fatty acids enter mitochondria via the carnitine shuttle, undergo repeated beta-oxidation cycles to produce acetyl-CoA, and how acetyl-CoA can alternatively be diverted into fatty acid synthesis in the cytosol when energy is plentiful.

Worked example Beginner

How many ATP does complete oxidation of palmitate (C16:0) produce?

Palmitate has 16 carbons. Beta-oxidation cleaves two carbons per round, so it takes 7 rounds to convert palmitoyl-CoA into 8 acetyl-CoA molecules.

Each round of beta-oxidation generates 1 FADH₂ and 1 NADH. Using the standard P/O ratios (1.5 ATP per FADH₂, 2.5 ATP per NADH):

• 7 rounds yield 7 FADH₂ → 10.5 ATP
• 7 rounds yield 7 NADH → 17.5 ATP

Each of the 8 acetyl-CoA molecules enters the citric acid cycle, producing 3 NADH, 1 FADH₂, and 1 GTP per turn:

• 8 acetyl-CoA → 8 × 10 = 80 ATP

Subtotal: 10.5 + 17.5 + 80 = 108 ATP. However, activating the fatty acid to acyl-CoA costs 2 ATP equivalents (ATP → AMP + PPᵢ). Net yield: 106 ATP.

Compare this to glucose: 6 carbons yield roughly 30-32 ATP. Per carbon, palmitate is far more energy-rich.

Check your understanding Beginner

Formal definition Intermediate+

Beta-oxidation is the catabolic process by which fatty acyl-CoA molecules are sequentially shortened by two-carbon units through a four-step enzymatic cycle: oxidation by acyl-CoA dehydrogenase (producing FADH₂), hydration by enoyl-CoA hydratase, a second oxidation by L-3-hydroxyacyl-CoA dehydrogenase (producing NADH), and thiolysis by beta-ketothiolase (releasing acetyl-CoA and shortening the acyl chain by two carbons).

Fatty acid synthesis is the anabolic counterpart, catalyzed in eukaryotes by a single multifunctional polypeptide called fatty acid synthase (FAS). It uses malonyl-CoA as the two-carbon donor and proceeds through loading, condensation, first reduction, dehydration, and second reduction — extending the growing chain by two carbons per cycle.

The carnitine shuttle

Long-chain fatty acyl-CoA cannot cross the inner mitochondrial membrane. Transport requires the carnitine shuttle: CPT1 (carnitine palmitoyltransferase I) on the outer mitochondrial membrane converts acyl-CoA to acylcarnitine; the carnitine-acylcarnitine translocase exchanges acylcarnitine for free carnitine across the inner membrane; and CPT2 on the inner membrane reconverts acylcarnitine to acyl-CoA inside the matrix.

Odd-chain and unsaturated fatty acids

Most dietary fatty acids have even numbers of carbons and are fully saturated. Odd-chain fatty acids (e.g., C15, C17) produce propionyl-CoA in the final round of beta-oxidation, which is converted to succinyl-CoA via methylmalonyl-CoA and enters the citric acid cycle.

Unsaturated fatty acids require auxiliary enzymes. A cis-Δ³ double bond is isomerized to trans-Δ² by enoyl-CoA isomerase. A cis-Δ⁴ double bond encountered after the first oxidation step requires 2,4-dienoyl-CoA reductase followed by isomerization to continue beta-oxidation.

Fatty acid synthase cycle

Eukaryotic FAS is a 270 kDa homodimer, with each subunit containing all seven catalytic domains plus the acyl carrier protein (ACP) domain. The cycle proceeds as follows:

1. Loading. Acetyl-CoA is transferred to the ACP phosphopantetheine arm, then to the condensing enzyme (KS) active-site cysteine.
2. Condensation. Malonyl-CoA loads onto ACP; KS catalyzes decarboxylative condensation, forming acetoacetyl-ACP and releasing CO₂.
3. First reduction. Beta-ketoacyl-ACP reductase (KR) reduces the ketone to a hydroxyl using NADPH.
4. Dehydration. Beta-hydroxyacyl-ACP dehydratase (DH) removes water, creating a trans-double bond.
5. Second reduction. Enoyl-ACP reductase (ER) reduces the double bond using NADPH, yielding a saturated acyl-ACP two carbons longer.

The product transfers to KS and the cycle repeats. After seven cycles, a C16 palmitoyl-ACP is released by the thioesterase domain.

NADPH sources

Fatty acid synthesis consumes two NADPH per two-carbon addition. The primary sources are:

• Malic enzyme: oxaloacetate → malate → pyruvate, generating one NADPH per citrate exported from mitochondria.
• Pentose phosphate pathway: glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase produce two NADPH per glucose-6-phosphate oxidized.

Regulation: acetyl-CoA carboxylase and CPT1

Acetyl-CoA carboxylase (ACC) catalyzes the committed step of fatty acid synthesis — carboxylation of acetyl-CoA to malonyl-CoA. ACC is activated by citrate (allosteric) and insulin-stimulated dephosphorylation, and inhibited by palmitoyl-CoA, glucagon-stimulated phosphorylation, and AMP-activated protein kinase (AMPK).

The malonyl-CoA produced by ACC serves a dual role: it is the substrate for FAS and it inhibits CPT1, preventing simultaneous fatty acid synthesis and oxidation. This reciprocal regulation ensures the two pathways do not run at the same time.

Key mechanism Intermediate+

Stoichiometry of beta-oxidation for a saturated, even-chain fatty acid

For a saturated fatty acid with n carbons (where n is even):

• Rounds of beta-oxidation: (n / 2) − 1
• Acetyl-CoA produced: n / 2
• FADH₂ produced: (n / 2) − 1
• NADH produced: (n / 2) − 1

Net ATP yield (using standard P/O ratios of 1.5 for FADH₂ and 2.5 for NADH, and 10 ATP per acetyl-CoA through the citric acid cycle and electron transport chain):

Net ATP = 10(n/2) + 1.5(n/2 − 1) + 2.5(n/2 − 1) − 2

The final term (−2) accounts for the activation cost (ATP → AMP + PPᵢ). For palmitate (n = 16), this gives 10(8) + 1.5(7) + 2.5(7) − 2 = 80 + 10.5 + 17.5 − 2 = 106 ATP.

Unsaturation reduces the yield because each double bond skips one acyl-CoA dehydrogenase step, forfeiting one FADH₂. A mono-unsaturated C18 fatty acid (oleate) loses 1.5 ATP compared to stearate (C18:0).

Peroxisomal and alternative oxidation pathways Master

Peroxisomal beta-oxidation

Peroxisomes contain their own beta-oxidation machinery, distinct from the mitochondrial system. The first step uses acyl-CoA oxidase instead of acyl-CoA dehydrogenase, transferring electrons directly to O₂ to produce H₂O₂ rather than feeding the electron transport chain. Peroxisomal beta-oxidation is energetically less efficient (no ATP from the first oxidation step) but serves a different purpose: it shortens very-long-chain fatty acids (VLCFAs, C22–C26) to a length that mitochondrial enzymes can handle.

Zellweger syndrome results from defective peroxisome biogenesis (mutations in PEX genes). VLCFAs accumulate in tissues, causing severe neurological impairment, hepatomegaly, and early death. This condition illustrates that peroxisomal beta-oxidation is not redundant — it handles substrates the mitochondria cannot process.

Omega-oxidation

When beta-oxidation is impaired or overloaded, omega-oxidation provides a fallback. Cytochrome P450 enzymes (CYP4A subfamily) hydroxylate the terminal (omega) carbon of fatty acids. The resulting omega-hydroxy fatty acid is further oxidized to a dicarboxylic acid, which can enter beta-oxidation from either end. This pathway is normally minor but becomes significant in conditions like MCAD deficiency or fasting.

MCAD deficiency

Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common inherited disorder of fatty acid oxidation, with an incidence of approximately 1 in 15,000 in populations of Northern European descent. Patients cannot efficiently oxidize medium-chain fatty acids (C6–C12). During fasting or illness, this leads to hypoketotic hypoglycemia — blood sugar drops without the expected rise in ketone bodies, because the acetyl-CoA supply from fat oxidation is insufficient. Management consists of avoiding prolonged fasting and ensuring adequate carbohydrate intake during illness.

Ketogenesis

When acetyl-CoA production from beta-oxidation exceeds the capacity of the citric acid cycle (e.g., during prolonged fasting or low insulin states), the liver diverts acetyl-CoA into ketogenesis:

1. Two acetyl-CoA molecules condense to form acetoacetyl-CoA (thiolase, reverse of beta-oxidation final step).
2. HMG-CoA synthase adds a third acetyl-CoA, forming HMG-CoA.
3. HMG-CoA lyase cleaves HMG-CoA to release acetoacetate and acetyl-CoA.
4. Acetoacetate is reduced to beta-hydroxybutyrate (using NADH) or spontaneously decarboxylated to acetone.

Acetoacetate and beta-hydroxybutyrate are exported to peripheral tissues, where they are converted back to acetyl-CoA for energy production. The brain, which normally relies on glucose, can derive up to 70% of its energy from ketone bodies during extended fasting.

Diabetic ketoacidosis

In uncontrolled Type 1 diabetes, insulin deficiency permits unregulated lipolysis and beta-oxidation. The resulting flood of acetyl-CoA overwhelms both the citric acid cycle (because gluconeogenesis depletes oxaloacetate) and the capacity for ketone utilization. Ketone body accumulation lowers blood pH below 7.35, producing diabetic ketoacidosis (DKA) — a medical emergency. The ketone breath odor (acetone) and Kussmaul respirations (deep, rapid breathing to compensate for metabolic acidosis) are characteristic clinical signs.

Non-alcoholic fatty liver disease (NAFLD)

Chronic imbalance between fatty acid synthesis and oxidation leads to hepatic steatosis. When lipid synthesis and dietary intake exceed the liver's capacity for beta-oxidation and VLDL export, triglycerides accumulate in hepatocytes. This can progress to steatohepatitis (NASH), fibrosis, and cirrhosis. The central role of ACC and FAS in this pathology has made them drug targets: ACC inhibitors (e.g., firsocostat) reduce malonyl-CoA production, decreasing fatty acid synthesis while simultaneously relieving CPT1 inhibition to promote oxidation.

Brown adipose tissue and thermogenesis

Brown adipose tissue (BAT) expresses uncoupling protein 1 (UCP1) in its inner mitochondrial membrane. UCP1 creates a proton leak that dissipates the proton gradient without generating ATP. When fatty acids are released from triglycerides in BAT (stimulated by norepinephrine in response to cold), beta-oxidation proceeds at high rates but the energy is released as heat rather than captured as ATP. This nonshivering thermogenesis is important in neonates and persists in significant quantities in adult humans, particularly in the supraclavicular and paravertebral regions.

Connections Master

Fatty acid metabolism sits at a crossroads of nearly every major metabolic pathway:

• Glycolysis and the citric acid cycle feed acetyl-CoA into fatty acid synthesis when glucose is abundant. The pyruvate dehydrogenase complex controls the flux of carbohydrate-derived carbon into the fat pool.
• The pentose phosphate pathway supplies the NADPH required for fatty acid synthesis. In tissues with high lipogenic rates (liver, adipose, lactating mammary gland), glucose-6-phosphate dehydrogenase expression is upregulated.
• Cholesterol biosynthesis begins with the same acetyl-CoA pool. HMG-CoA reductase and ACC compete for shared regulatory inputs (AMPK phosphorylation, insulin/glucagon ratio).
• Amino acid metabolism intersects at several points: leucine and lysine are purely ketogenic (degraded to acetyl-CoA or acetoacetyl-CoA), while isoleucine, tryptophan, phenylalanine, and tyrosine are both ketogenic and glucogenic.
• The fasting/feeding cycle orchestrates reciprocal regulation: insulin promotes lipogenesis (SREBP-1c activation, ACC dephosphorylation) while glucagon and epinephrine promote beta-oxidation (hormone-sensitive lipase activation, ACC phosphorylation via PKA and AMPK).
• Signal transduction connects lipid metabolism to cell growth: phosphatidic acid and diacylglycerol are derived from fatty acid metabolism and serve as signaling molecules; mTORC1 is activated by lipid-derived signals; and AMPK acts as a master sensor linking energy status to lipid flux.

Historical notes Master

The discovery of beta-oxidation is credited to Franz Knoop (1904), who fed dogs odd- and even-chain omega-phenyl fatty acids and found that odd-chain substrates yielded phenylpropionate while even-chain substrates yielded phenylacetate in the urine. This established that fatty acids are degraded two carbons at a time from the carboxyl end.

The enzymatic steps were elucidated in the 1950s by Lynen, Green, and Lynen's group, who isolated the four enzymes of the mitochondrial beta-oxidation spiral. Lynen also characterized fatty acid synthase from yeast, showing that acetyl- and malonyl-groups are bound as thioesters to a "swinging arm" later identified as the phosphopantetheine prosthetic group of ACP.

Salih Wakil and collaborators (1958–1961) established the mammalian fatty acid synthase system, identifying malonyl-CoA as the two-carbon donor and acetyl-CoA carboxylase as the committed-step enzyme. Wakil's 2008 review in the Journal of Lipid Research provides a comprehensive account of the discovery and characterization of FAS.

The carnitine shuttle was characterized by Bremer and Fritz in the 1960s, establishing the essential role of carnitine in mitochondrial fatty acid transport. McGarry and Foster (1970s–1980s) demonstrated that malonyl-CoA is the physiological inhibitor of CPT1, providing the mechanism linking fatty acid synthesis to the suppression of oxidation.

The peroxisomal oxidation pathway was discovered by Lazarow and de Duve (1976), expanding the understanding of fatty acid metabolism beyond the mitochondrial system.

Exercises Intermediate+

Bibliography Master

1. Alberts, B., Hopkin, K., Johnson, A., Morgan, D., Roberts, K., & Walter, P. — Molecular Biology of the Cell, 7th ed. (Garland Science, 2022). Chapters 2 and 12.

2. Berg, J. M., Tymoczko, J. L., & Stryer, L. — Biochemistry, 9th ed. (W. H. Freeman, 2019). Chapter 22: Fatty Acid Metabolism.

3. Vance, D. E. & Vance, J. E. — Biochemistry of Lipids, Lipoproteins and Membranes, 5th ed. (Elsevier, 2008). Chapters 5 and 6.

4. Wakil, S. J. — "Fatty acid synthase, a proficient multifunctional enzyme." J. Lipid Res. 49 (2008): 1–23.

5. Knoop, F. — "Der Abbau aromatischer Fettsäuren im Tierkörper." Beitr. Chem. Physiol. Pathol. 6 (1904): 150–162.

6. McGarry, J. D. & Foster, D. W. — "Regulation of hepatic fatty acid oxidation and ketone body production." Annu. Rev. Biochem. 49 (1980): 395–420.

7. Lazarow, P. B. & de Duve, C. — "A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug." Proc. Natl. Acad. Sci. USA 73 (1976): 2043–2046.